Osteosarcoma · None

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Track	aggressive
Linked regimen	`None`

ID	`IND-ROTHMUND-THOMSON-CARRIER-INTENSIFIED`
Type	Indication
Status	reviewed 2026-05-20 \| pending_clinical_signoff
Diseases	`DIS-OSTEOSARCOMA`
Sources	`SRC-NCCN-BONE-SARCOMA` `SRC-NCCN-SKIN-2025`

Notes

STUB — Wave O confirmed-carrier intensified track (RTS). Sibling — IND-ROTHMUND-THOMSON-CARRIER-SURVEILLANCE. §15.2 C4 ≥2-tracks invariant compliance.

Used By

Indication

IND-ROTHMUND-THOMSON-CARRIER-SURVEILLANCE - IND-ROTHMUND-THOMSON-CARRIER-SURVEILLANCE

Red flag

RF-ROTHMUND-THOMSON-CONFIRMED-CARRIER - Confirmed biallelic germline pathogenic / likely-pathogenic variants in RECQL4 (RecQ-like...